Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3020 |
|
| Actual shortage: | 235 (8%) | |
| Anticipated shortage: | 19 (1%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2757 (91%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
28 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-MEDROXY | 100MG | TABLET | Resolved | 2021-08-27 | 2022-01-31 | 144662 |
| APO-TADALAFIL | 10MG | TABLET | Resolved | 2021-08-27 | 2021-09-14 | 144669 |
| APO-ENALAPRIL | 20MG | TABLET | Resolved | 2021-08-27 | 2022-07-11 | 144672 |
| APO-DABIGATRAN | 150MG | CAPSULE | Resolved | 2021-09-03 | 2023-09-15 | 145144 |
| APO-DOXY CAP 100MG | 100MG | CAPSULE | Resolved | 2021-09-03 | 2021-09-20 | 145147 |
| APO-METHYLPHENIDATE ER | 54MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-09-03 | 2021-11-08 | 145150 |
| APO-PERINDOPRIL | 4MG | TABLET | Resolved | 2021-09-03 | 2021-09-27 | 145153 |
| APO-PIOGLITAZONE | 30MG | TABLET | Resolved | 2021-09-03 | 2021-09-20 | 145178 |
| APO-SIMVASTATIN | 10MG | TABLET | Resolved | 2021-09-03 | 2021-10-25 | 145181 |
| APO-RISEDRONATE | 150MG | TABLET | Resolved | 2021-09-10 | 2022-03-04 | 145468 |
| APO-ACYCLOVIR | 400MG | TABLET | Resolved | 2021-09-17 | 2021-09-27 | 145818 |
| APO-CEFEPIME | 2G | POWDER FOR SOLUTION | Resolved | 2021-09-17 | 2021-10-25 | 145822 |
| APO-CEFUROXIME | 250MG | TABLET | Resolved | 2021-09-17 | 2021-10-12 | 145828 |
| APO-DESVENLAFAXINE | 100MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-09-17 | 2021-10-12 | 145831 |
| APO-DONEPEZIL | 10MG | TABLET | Resolved | 2021-09-17 | 2021-09-27 | 145834 |
| APO-GABAPENTIN | 400MG | CAPSULE | Resolved | 2021-09-17 | 2021-11-22 | 145837 |
| APO-RIZATRIPTAN | 5MG | TABLET | Resolved | 2021-09-17 | 2021-11-08 | 145843 |
| APO-HYDROMORPHONE | 8MG | TABLET | Resolved | 2021-09-21 | 2021-10-25 | 145937 |
| APO-METHYLPHENIDATE ER | 36MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-09-21 | 2021-10-28 | 145949 |
| APO-ACETAMINOPHEN | 325MG | TABLET | Resolved | 2021-09-24 | 2021-09-28 | 146151 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71342 |
| APO-TELMISARTAN | 40MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71345 |
| APO-AMITRIPTYLINE | 10MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71348 |
| APO-AMITRIPTYLINE | 25MG | TABLET | Discontinued | 2019-01-04 | 2019-02-13 | 71351 |
| IBUPROFEN | 200MG | TABLET | Discontinued | 2019-01-07 | 2019-01-07 | 71436 |
| IBUPROFEN | 200MG | TABLET | Discontinued | 2019-01-07 | 2019-07-22 | 71439 |
| IBUPROFEN CAPLETS | 400MG | TABLET | Discontinued | 2019-01-07 | 2019-07-13 | 71451 |
| APO-DILTIAZ CD | 300MG | CAPSULE (CONTROLLED-DELIVERY) | Discontinued | 2019-02-01 | 2019-02-02 | 74366 |
| APO-LOSARTAN | 25MG | TABLET | Discontinued | 2019-02-01 | 2019-02-02 | 74376 |
| APO PEN VK | Discontinued | 2019-03-08 | 2019-03-08 | 78141 | ||
| APO PEN VK | Discontinued | 2019-03-08 | 2019-03-08 | 78144 | ||
| APO-NEVIRAPINE XR | 400MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2019-03-11 | 2019-03-11 | 78257 |
| APO-SOLIFENACIN | 10MG | TABLET | Discontinued | 2019-03-11 | 2019-09-20 | 78269 |
| APO-SOLIFENACIN | 5MG | TABLET | Discontinued | 2019-03-11 | 2019-09-20 | 78272 |
| APO-ALMOTRIPTAN | Discontinued | 2019-05-13 | 2019-05-13 | 83971 | ||
| APO-ALMOTRIPTAN | Discontinued | 2019-05-13 | 2019-05-13 | 83976 | ||
| APO-AMOXI CLAV 250MG/62.5MG PER 5ML | Discontinued | 2019-05-13 | 2019-05-13 | 83981 | ||
| APO-AMOXI CLAV | Discontinued | 2019-05-17 | 2019-05-18 | 84392 | ||
| APO-CEFPROZIL | Discontinued | 2019-05-17 | 2019-05-18 | 84396 | ||
| APO-CEFPROZIL | Discontinued | 2019-06-12 | 2019-06-12 | 86542 |